Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2010
12/30/2010US20100330560 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/30/2010US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy
12/30/2010US20100330551 Novel Restriction Endonucleases, DNA Encoding These Endonucleases and Methods for Identifying New Endonucleases with the Same or Varied Specificity
12/30/2010US20100330253 Barely with reduced SSII activity and starch and starch containing products with a reduced amylopectin content
12/30/2010US20100330190 Immunogenic compositions and methods of use thereof
12/30/2010US20100330160 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6
12/30/2010US20100330155 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA
12/30/2010US20100330152 Methods and compositons for antisense vegf oligonucleotides
12/30/2010US20100330126 Attenuated malaria blood-stage vaccine
12/30/2010US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330113 Vaccine Antigens
12/30/2010US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330095 Axl antibodies
12/30/2010US20100330091 Immunoreactive glycoprotein gp19 ehrlichia canis
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330082 Nlrr-1 antagonists and uses thereof
12/30/2010US20100330080 Antigen binding polypeptides
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
12/30/2010US20100330059 Chimeric factor vii molecules
12/30/2010US20100330053 Mixed-cell gene therapy
12/30/2010US20100330046 Human skin substitutes expressing il-12
12/30/2010US20100330039 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto
12/30/2010US20100330038 Methods for expressing proteins in axons
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100329990 Luminescent markers
12/30/2010US20100329988 Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active Polypeptide
12/30/2010US20100329981 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/30/2010DE112009000453T5 Vektor zur Transformation unter Verwendung von Transposons, durch den Vektor transformierte Mikroorganismen und Verfahren zum Herstellen von L-Lysin unter Verwendung derselben Vector for transformation using transposons, microorganisms transformed by the vector and methods for producing L-lysine using the same
12/30/2010DE102009030643A1 Water treatment plant comprises biosensor that has genetically modified yeast comprising e.g. first expression cassette for expression of retinoid X receptor gene, and second expression cassette for expression of pregnane X receptor gene
12/30/2010DE102009030342A1 Verfahren zur fermentativen Herstellung von organisch chemischen Verbindungen A process for the fermentative production of organic chemical compounds
12/30/2010DE102009027045A1 Neue Proteasen und Mittel enthaltend diese Proteasen New proteases and compositions comprising these proteases
12/29/2010WO2010151880A2 Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same
12/29/2010WO2010151854A2 Lttr-modulated expression in gentically modified photosynthetic organisms
12/29/2010WO2010151827A1 X-box binding proteins (xbp-1) variants and methods of using the same
12/29/2010WO2010151808A1 Expression of surrogate light chains
12/29/2010WO2010151733A1 Dental stem cell reprogramming
12/29/2010WO2010151703A1 Stabilizing alkylglycoside compositions and methods thereof
12/29/2010WO2010151674A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/29/2010WO2010151671A2 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
12/29/2010WO2010151656A2 Compositions and methods for identification of parp function, inhibitors, and activators
12/29/2010WO2010151640A2 Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease
12/29/2010WO2010151634A1 Methods for agrobacterium-mediated transformation of sugar cane
12/29/2010WO2010151169A1 Oligonucleotide and a conjugate thereof for detecting proteins in an amyloid state and a method for detecting proteins in an amyloid state
12/29/2010WO2010151133A1 Methods for establishing and predicting resistance to endocrine therapy using an mirna profile
12/29/2010WO2010150901A1 Mutant for increasing oleic acid content of soybean oil and fat, and responsible gene therefor
12/29/2010WO2010150862A1 Fluorescent temperature probe and temperature measuring device using same
12/29/2010WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150375A1 Modified biotin-conjugated protein
12/29/2010WO2010150282A1 Novel polynucleotide molecules for enhanced gene expression
12/29/2010WO2010150231A1 Antisense oligonucleotides capable of inducing exon skipping and the use thereof as a medicament for the treatment of duchenne muscular dystrophy (dmd)
12/29/2010WO2010150230A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives
12/29/2010WO2010150213A1 Protein
12/29/2010WO2010150159A1 Anticancer agent specific for brain tumors with mechanism of recq1 suppression
12/29/2010WO2010150004A1 Novel drugs for inhibition of gene expression
12/29/2010WO2010149765A1 Non human animal models for increased retinal vascular permeability
12/29/2010WO2010149721A1 A method for transforming a bacterium belonging to the streptococcus genus by natural competence
12/29/2010WO2010149574A1 Method for fermentatively preparing l-amino acids
12/29/2010WO2010149532A1 Process for amplifying dna using tetraethylene glycol, kit of parts therefor and use thereof
12/29/2010WO2010149350A1 Device for singularizing micro-objects
12/29/2010WO2010149322A1 Polyploid plants
12/29/2010WO2010148511A1 Chimeric influenza virus-like particles comprising hemagglutinin
12/29/2010WO2010148496A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
12/29/2010WO2010148459A1 Synthetic operon
12/29/2010WO2010148447A1 A novel regulator of cellular senescence
12/29/2010WO2010130898A3 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
12/29/2010WO2010129540A3 Novel sugar transporters
12/29/2010WO2010127420A9 Genetically modified sequences encoding plasmodium vivax antigens
12/29/2010WO2010125471A3 Gene vector
12/29/2010WO2010122531A3 Method of producing a lipolytic enzyme
12/29/2010WO2010122426A3 Methods and compositions for visualization of fluorescent proteins
12/29/2010WO2010111490A3 RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/29/2010WO2010083253A3 Cd47 related compositions and methods for treating immunological diseases and disorders
12/29/2010WO2010065470A3 Compositions and methods for detecting background male dna during fetal sex determination
12/29/2010WO2010054108A9 Cas6 polypeptides and methods of use
12/29/2010WO2010008582A3 Phagocytic cell delivery of rnai
12/29/2010WO2009146463A8 Variant hhip1 protein and methods and uses thereof
12/29/2010WO2007122086A8 Transgenic plants and methods for controlling bolting in sugar beet
12/29/2010WO2006072946A3 Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
12/29/2010EP2267458A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/29/2010EP2267454A2 Diagnosis and prevention of cancer cell invasion
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267448A1 Composition, kit and method for detecting neuropathy
12/29/2010EP2267447A1 Composition, kit and method for detecting aging and disease associated with vascular disorder
12/29/2010EP2267431A2 Gas sensor
12/29/2010EP2267165A2 Nucleic acid sequence analysis
12/29/2010EP2267164A2 Nucleic acid sequence analysis
12/29/2010EP2267163A1 In vitro evolution in microfluidic systems
12/29/2010EP2267160A1 Method for alteration detection in nucleic acids
12/29/2010EP2267158A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267157A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267156A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/29/2010EP2267155A2 Method for detecting human papillomavirus mRNA
12/29/2010EP2267154A1 Oligoadenylate synthetase
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 4023